Predictive AI Model Identifies 55% of Commercially Insured Women Unlikely to Get a Mammogram
GREENWICH, Conn.--(BUSINESS WIRE)--Oct 24, 2023--<a ...
GREENWICH, Conn.--(BUSINESS WIRE)--Oct 24, 2023--<a ...
NASHVILLE, Tenn. (AP) — ItĢƵ long after midnight when the bustling operating room suddenly falls quiet — a moment of silence to honor the man lying on the table.This is no ordinary surgery. Detrick Witherspoon died before ever being wheeled in, and now two wide-eyed medical students are ...
BURLINGTON, Mass.--(BUSINESS WIRE)--Oct 24, 2023--<a ...
SOMERVILLE, Mass.--(BUSINESS WIRE)--Oct 24, 2023--<em>bluebird bio, Inc.</em> (Nasdaq: BLUE) announced today that it will host a conference call to discuss third quarter 2023 financial results and business updates on Tuesday, November 7 at 8:00 a.m. ET.To access the ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 24, 2023--Ankyra Therapeutics, a clinical stage biotechnology company pioneering anchored immunotherapies to treat cancer, today announced approval of its investigational new drug (IND) application by the U.S. Food & Drug Administration (FDA) ...
SAN FRANCISCO & LONDON--(BUSINESS WIRE)--Oct 24, 2023--Aiolos Bio, Inc. (“Aiolos” or “the Company”) today announced its launch as a clinical-stage biopharmaceutical company focused on addressing the unmet treatment needs of patients with respiratory and inflammatory ...